{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:51:11Z","timestamp":1778575871125,"version":"3.51.4"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.pharma.2017.07.005","type":"journal-article","created":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T21:45:15Z","timestamp":1503524715000},"page":"16-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Validated spectrophotometric and chromatographic methods for analysis of the recently approved hepatitis C antiviral combination ledipasvir and sofosbuvir"],"prefix":"10.1016","volume":"76","author":[{"given":"M.M.","family":"Baker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.S.","family":"El-Kafrawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.S.","family":"Mahrous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.S.","family":"Belal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.pharma.2017.07.005_bib0005","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1586\/17512433.2016.1129272","article-title":"New direct-acting antivirals in hepatitis C therapy: a review of sofosbuvir, ledipasvir, daclatasvir, simeprevir, paritaprevir, ombitasvir and dasabuvir","volume":"9","author":"McConachie","year":"2016","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.pharma.2017.07.005_bib0010","first-page":"41","article-title":"Approaches to hepatitis C treatment and cure using NS5A inhibitors","volume":"7","author":"Kohler","year":"2014","journal-title":"Infect Drug Resist"},{"issue":"4","key":"10.1016\/j.pharma.2017.07.005_bib0015","first-page":"331","article-title":"Sofosbuvir: a novel oral agent for chronic hepatitis C","volume":"27","author":"Cholongitas","year":"2014","journal-title":"Ann Gastroenterol"},{"issue":"2","key":"10.1016\/j.pharma.2017.07.005_bib0020","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s40265-014-0179-7","article-title":"Sofosbuvir: first global approval","volume":"74","author":"Keating","year":"2014","journal-title":"Drugs"},{"issue":"8","key":"10.1016\/j.pharma.2017.07.005_bib0025","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1177\/1060028014534194","article-title":"Sofosbuvir: a nucleotide NS5B inhibitor for the treatment of chronic hepatitis C infection","volume":"48","author":"Rose","year":"2014","journal-title":"Ann Pharmacother"},{"issue":"5","key":"10.1016\/j.pharma.2017.07.005_bib0030","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1021\/jm401499g","article-title":"Discovery of ledipasvir (GS-5885): a potent, once-daily oral NS5A inhibitor for the treatment of hepatitis C virus infection","volume":"57","author":"Link","year":"2014","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.pharma.2017.07.005_bib0035","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/1060028014563952","article-title":"Ledipasvir-Sofosbuvir: interferon-\/ribavirin-free regimen for chronic hepatitis C virus infection","volume":"49","author":"Smith","year":"2015","journal-title":"Ann Pharmacother"},{"issue":"11","key":"10.1016\/j.pharma.2017.07.005_bib0040","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s40262-016-0397-0","article-title":"Clinical pharmacokinetics and pharmacodynamics of ledipasvir\/sofosbuvir, a fixed-dose combination tablet for the treatment of hepatitis C","volume":"55","author":"German","year":"2016","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.pharma.2017.07.005_bib0045","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jchromb.2015.11.056","article-title":"Simultaneous determination of ledipasvir, sofosbuvir and its metabolite in rat plasma by UPLC-MS\/MS and its application to a pharmacokinetic study","volume":"1008","author":"Pan","year":"2016","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"5","key":"10.1016\/j.pharma.2017.07.005_bib0050","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.5740\/jaoacint.16-0021","article-title":"A rapid and optimized LC-MS\/MS method for the simultaneous extraction and determination of sofosbuvir and ledipasvir in human plasma","volume":"99","author":"Elkady","year":"2016","journal-title":"J AOAC Int"},{"issue":"23\u201324","key":"10.1016\/j.pharma.2017.07.005_bib0055","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s10337-016-3179-9","article-title":"RP-HPLC method for simultaneous determination of sofosbuvir and ledipasvir in tablet dosage form and its application to in vitro dissolution studies","volume":"79","author":"Zaman","year":"2016","journal-title":"Chromatographia"},{"issue":"3","key":"10.1016\/j.pharma.2017.07.005_bib0060","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.pharma.2016.12.005","article-title":"Validated stability-indicating HPLC-DAD method for determination of the recently approved hepatitis C antiviral agent daclatasvir","volume":"75","author":"Baker","year":"2017","journal-title":"Ann Pharm Fr"},{"issue":"2","key":"10.1016\/j.pharma.2017.07.005_bib0065","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jpha.2012.10.004","article-title":"New simple spectrophotometric method for determination of the binary mixtures (atorvastatin calcium and ezetimibe; candesartan cilexetil and hydrochlorothiazide) in tablets","volume":"3","author":"Belal","year":"2013","journal-title":"J Pharm Anal"},{"issue":"S2","key":"10.1016\/j.pharma.2017.07.005_bib0070","doi-asserted-by":"crossref","first-page":"S1741","DOI":"10.1016\/j.arabjc.2013.06.024","article-title":"New simple spectrophotometric method for determination of the antiviral mixture of emtricitabine and tenofovir disoproxil fumarate","volume":"10","author":"Ashour","year":"2017","journal-title":"Arab J Chem"},{"issue":"2","key":"10.1016\/j.pharma.2017.07.005_bib0075","first-page":"552","article-title":"Application of a new simple spectrophotometric method to the simultaneous determination of diclofenac sodium and diflunisal in their combined dosage form","volume":"5","author":"Belal","year":"2014","journal-title":"Res J Pharm Biol Chem Sci"},{"issue":"4","key":"10.1016\/j.pharma.2017.07.005_bib0080","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.pharma.2015.12.006","article-title":"Validated spectrophotometric and chromatographic methods for simultaneous determination of ketorolac tromethamine and phenylephrine hydrochloride","volume":"74","author":"Belal","year":"2016","journal-title":"Ann Pharm Fr"},{"key":"10.1016\/j.pharma.2017.07.005_bib0085","unstructured":"http:\/\/www.drugbank.ca\/. [Last time accessed: May 10th, 2017]."},{"key":"10.1016\/j.pharma.2017.07.005_bib0090","series-title":"International Conference on Harmonisation","article-title":"Q2A (R1). Validation of analytical procedures: text and methodology","author":"ICH","year":"2005"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450917300755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450917300755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T23:32:44Z","timestamp":1757719964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450917300755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0003450917300755"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2017.07.005","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validated spectrophotometric and chromatographic methods for analysis of the recently approved hepatitis C antiviral combination ledipasvir and sofosbuvir","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2017.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}